Institutes & Pharma Co Running a Race to Deliver COVID-19 Vaccine

Elisa Granato, Molecular Microbiologist of University of Oxford
was the first volunteer in the Oxford vaccine trial for COVID-19

As I joined my medical career in 2007, there was a different drug practice, and now it has changed a lot. My pharma textbook had mere 10 sentences on carbapenems but they became ubiquitous in present critical care units. For last 5 years (atleast) I saw a good number of drugs being approved by FDA, many of them are monoclonal antibodies (mab) for autoimmune diseases or for cancer treatment. I am not sure about their efficacy but I know these are not cheap! 

However as 2020 saw a pandemic of COVID-19 by beta coronavirus, I can see a race to deliver potential vaccine candidate to humankind is already started by educational institutes as well as pharma companies.